Expression of Toll-like Receptors in the Pancreas of Recent-onset Fulminant Type 1 Diabetes
Saeko Shibasaki(Osaka Medical and Pharmaceutical University), Toshiaki Hanafusa(Osaka Medical and Pharmaceutical University), Hiroaki Seino, Hitoshi Abiru(Kyoto University), Heikki Hyöty(Tampere University of Applied Sciences), Akihisa Imagawa(The University of Osaka), Keiji Tamaki(Kyoto University), Morio Iino(Nagoya City University), Sae Uno(The University of Osaka), Jungo Terasaki(Osaka Medical and Pharmaceutical University), Iichiro Shimomura(The University of Osaka), Maarit Oikarinen(Tampere University), Yuko Murase‐Mishiba(Osaka Medical and Pharmaceutical University), Katsuhiro Nishi(Shiga University of Medical Science), Yoshikatsu Okada(Brigham and Women's Hospital), Izumi Takase(Shiga University of Medical Science), Hideichi Makino, Sisko Tauriainen(University of Turku)
Cited by 91
Related Papers
Absence of Monocyte Chemoattractant Protein-1 Reduces Atherosclerosis in Low Density Lipoprotein Receptor–Deficient Mice
|Molecular Cell|1998|1.6k
Toward defining the autoimmune microbiome for type 1 diabetes
|The ISME Journal|2010|814
Gut Microbiome Metagenomics Analysis Suggests a Functional Model for the Development of Autoimmunity for Type 1 Diabetes
|PLoS ONE|2011|786
Differential expression of exons 1a and 1c in mRNAs for sterol regulatory element binding protein-1 in human and mouse organs and cultured cells.
|Journal of Clinical Investigation|1997|754